Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-3-31
pubmed:abstractText
Increased levels of plasminogen activator inhibitor-1 (PAI-1) have been associated with worse outcome in ALI/ARDS. A single guanosine insertion/deletion (4G/5G) polymorphism in the promoter region of the PAI-1 gene, may play an important role in the regulation of PAI-1 expression. The objective of the study was to evaluate the effect of this polymorphism on the outcome of critically ill patients with ALI/ARDS.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0049-3848
pubmed:author
pubmed:issnType
Print
pubmed:volume
123
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
832-6
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS.
pubmed:affiliation
2nd Department of Critical Care Medicine, Attikon Hospital, Medical School, University of Athens, Athens, Greece. itsagkaris@med.uoa.gr
pubmed:publicationType
Journal Article